Literature DB >> 16168348

The Bayesian Alcoholism Test had better diagnostic properties for confirming diagnosis of hazardous and harmful alcohol use.

Aleksander Korzec1, Carla de Bruijn, Michiel van Lambalgen.   

Abstract

OBJECTIVE: Conventional tests for alcoholism fail to confirm hazardous and harmful alcohol use (HHAU) accurately and objectively. We validated a Bayesian Alcoholism Test (BAT) for confirming the diagnosis of HHAU. STUDY DESIGN AND
SETTING: BAT is based on studies on the prevalence of HHAU and other diseases causing similar abnormalities, and on conditional probabilities of these disorders and associated biochemical markers and clinical signs. BAT was compared to carbohydrate-deficient transferrin (CDT) and gamma-glutamyltransferase (GGT) in treatment-seeking alcoholics, non-treatment-seeking heavy drinkers, and controls. Main outcome measures were test sensitivity and specificity, likelihood ratios, and receiver-operating characteristic (ROC) curves.
RESULTS: Comparing alcoholics and controls, sensitivity of BAT (94%) was significantly higher than CDT (63%) and GGT (73%). The area under the ROC curve for BAT (.989) was significantly higher than the area under the curve for CDT (.909) and area under the curve for GGT (.902). Using pooled data of all 182 subjects included in the study, the amount of drinking had a significant better correlation coefficient with BAT (.795) than with CDT (.657), and GGT (.604).
CONCLUSION: BAT has better diagnostic properties than CDT and GGT for confirming HHAU.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16168348     DOI: 10.1016/j.jclinepi.2005.02.020

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  4 in total

1.  Future prospects for biomarkers of alcohol consumption and alcohol-induced disorders.

Authors:  Willard M Freeman; Kent E Vrana
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

Review 2.  Circulating cytokines as biomarkers of alcohol abuse and alcoholism.

Authors:  Rajeshwara N Achur; Willard M Freeman; Kent E Vrana
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-18       Impact factor: 4.147

3.  Plasma proteomic alterations in non-human primates and humans after chronic alcohol self-administration.

Authors:  Willard M Freeman; Heather D Vanguilder; Elizabeth Guidone; John H Krystal; Kathleen A Grant; Kent E Vrana
Journal:  Int J Neuropsychopharmacol       Date:  2011-02-08       Impact factor: 5.176

4.  Validation of the Bayesian Alcoholism Test compared to single biomarkers in detecting harmful drinking.

Authors:  Sanne Korzec; Alex Korzec; Katherine Conigrave; Janneke Gisolf; Boris Tabakoff
Journal:  Alcohol Alcohol       Date:  2009-03-16       Impact factor: 2.826

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.